Researchers have successfully developed a deep learning model that classifies pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, into molecular subtypes using ...

Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the ...

Candel Therapeutics' CAN-2409 shows a 14.5% improvement in prostate cancer survival. Discover why CADL stock stays a "Buy" ...

Therapeutics is pleased to showcase its survival and clinical benefit data in MBC patients, including those with CNS ...

Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...

Experts discussed what other information is needed to understand how best to use Kisqali in treating patients in the adjuvant ...

Metastasis is responsible for 90 percent of cancer deaths. Researchers have found that the mutations driving it may stem from a commonly inherited variant of the PCSK9 gene.

The number of women with late-stage, invasive breast cancer at the time of diagnosis increased significantly among U.S. women ...

A paper published by the Asia-Pacific Medical Technology Association in June showed that 51 out of 100 cancer patients in ...

Pediatric cancer survival rates are a crowning medical achievement. But the impact of missing school is a less-discussed side ...

By targeting cancer from two different angles, this treatment could enhance the immune response, improving survival rates and quality of life. The potential implications are vast, with this therapy ...